Literature DB >> 11372576

Utilitarianism and the measurement and aggregation of quality--adjusted life years.

P Dolan1.   

Abstract

It is widely accepted that one of the main objectives of government expenditure on health care is to generate health. Since health is a function of both length of life and quality of life, the quality-adjusted life-year (QALY) has been developed in an attempt to combine the value of these attributes into a single index number. The QALY approach--and particularly the decision rule that health care resources should be allocated so as to maximise the number of QALYs generated--has often been equated with the utilitarian philosophy of maximising 'the greatest happiness of the greatest number'. This paper considers the extent to which the measurement and aggregation of QALYs really is utilitarian by developing a new taxonomy in order to classify utilitarianism and the different aspects of the QALY approach. It is shown that the measurement of QALYs is consistent with a number of different moral positions and that QALYs do not have to be aggregated according to the maximisation rule. Therefore it is inappropriate to necessarily equate QALYs with utilitarianism. It is shown that much turns on what in principle the QALY represents and how in practice it can be operationalised. The paper highlights the category confusion that is often present here and suggests possible avenues for future theoretical and empirical research.

Keywords:  Analytical Approach; Health Care and Public Health; Philosophical Approach

Mesh:

Year:  2001        PMID: 11372576     DOI: 10.1023/A:1011387524579

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  7 in total

1.  Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?

Authors:  H Bleichrodt; J Quiggin
Journal:  J Health Econ       Date:  1999-12       Impact factor: 3.883

2.  What is the good of health care?

Authors:  John Harris
Journal:  Bioethics       Date:  1996-10       Impact factor: 1.898

3.  Vertical equity: weighting outcomes? or establishing procedures?

Authors:  G Mooney; S Jan
Journal:  Health Policy       Date:  1997-01       Impact factor: 2.980

Review 4.  Equity and equality in health and health care.

Authors:  A J Culyer; A Wagstaff
Journal:  J Health Econ       Date:  1993-12       Impact factor: 3.883

5.  Patient involvement in health care. A procedural justice viewpoint.

Authors:  T E Hughes; L N Larson
Journal:  Med Care       Date:  1991-03       Impact factor: 2.983

6.  Fairness versus doing the most good.

Authors:  J Broome
Journal:  Hastings Cent Rep       Date:  1994 Jul-Aug       Impact factor: 2.683

7.  Publicity and pricelessness: grassroots decisionmaking and justice in rationing.

Authors:  J L Nelson
Journal:  J Med Philos       Date:  1994-08
  7 in total
  3 in total

1.  Evidence, ethics and inclusion: a broader base for NICE.

Authors:  Stephen Wilmot
Journal:  Med Health Care Philos       Date:  2011-05

2.  Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer.

Authors:  V Valentí; J Ramos; C Pérez; L Capdevila; I Ruiz; L Tikhomirova; M Sánchez; I Juez; M Llobera; E Sopena; J Rubió; R Salazar
Journal:  Clin Transl Oncol       Date:  2019-09-26       Impact factor: 3.405

Review 3.  Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness.

Authors:  Michael Schlander
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.